Robert F. Kennedy Jr. has completely overhauled the CDC’s vaccine advisory committee, dismissing all 17 existing members and appointing 8 new ones in a move that has sparked both strong support and intense criticism across the medical community.
At a Glance
- Kennedy, as Health and Human Services Secretary, removed all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP)
- He announced 8 new members, stating they are “committed to evidence-based medicine” and will help restore public trust
- ACIP is a critical committee that reviews vaccine safety and makes recommendations affecting insurance coverage and access
- The committee was scheduled to vote on COVID, flu, and RSV vaccine recommendations at their next meeting
- Health experts warn this restructuring could impact policies for all vaccines, not just COVID-19 vaccines
Complete Restructuring of CDC Vaccine Advisory Committee
Health and Human Services Secretary Robert F. Kennedy Jr. has taken decisive action by removing all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP). This influential committee, responsible for reviewing vaccine safety and effectiveness and making clinical recommendations, will now be reconstituted with new members. Kennedy announced the appointment of 8 new members to the committee, signaling a significant shift in the direction of vaccine policy in the United States.
The Biden administration had appointed all 17 of the dismissed committee members, with 13 of those appointments occurring in 2024 alone. ACIP’s recommendations are crucial as they influence immunization schedules, vaccine policies, and importantly, insurance coverage decisions. The committee was scheduled to vote on recommendations for COVID-19, influenza, and RSV vaccines at their upcoming meeting, plans that are now uncertain given the committee’s restructuring.
🚨 BREAKING: RFK Jr. has dismissed all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP), citing their conflicts of interest in shaping vaccine policy. He calls the action a “total overhaul to rebuild trust in vaccine science.”
“Today we are… pic.twitter.com/qpsbw8p7tp
— Kari Bundy (@truthwithkari) June 9, 2025
Kennedy’s Rationale for the Changes
Kennedy has framed this action as necessary to restore public trust in vaccine recommendations and prioritize what he calls “unbiased science.” In his announcement of the new appointees, Kennedy emphasized their qualifications and commitment to scientific standards. He has alleged that the previous committee had conflicts of interest and pointed out that ACIP had never recommended against a vaccine, suggesting this indicated potential bias in their decision-making process.
“All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense”, said Kennedy Jr.
The move appears to contradict Kennedy’s earlier promise to Senator Bill Cassidy not to make changes to the committee. Critics have noted this reversal, questioning the administration’s consistency on health policy matters. A CDC official reportedly resigned following Kennedy’s earlier announcement regarding changes to COVID-19 vaccine recommendations, highlighting the internal tensions created by the policy shift.
Health Secretary Robert F. Kennedy Jr. removed all 17 members of the CDC's immunization advisory committee on Monday. Kennedy stated the decision was aimed at rebuilding public trust in vaccines. The move marks a significant shake-up in vaccine policy oversight, sparking… pic.twitter.com/4vNaEOEKz3
— Wayne DuPree (@TheDupreeReport) June 9, 2025
Potential Impacts on Public Health
Health experts and organizations, including the American Medical Association, have expressed concern about the potential impacts of this restructuring. The ACIP has historically operated through an open process with diverse expertise, which many consider crucial for effective vaccine policy-making. There are fears that reconstituting the committee with members who may hold skeptical views on vaccines could limit vaccine access and undermine public health initiatives.
Former CDC directors have voiced alarm about the potential impact on public health and vaccine confidence. A particular concern involves insurance coverage for vaccines, as insurers typically follow ACIP recommendations when determining which immunizations to cover. Without ACIP endorsement, many vaccines might become inaccessible to Americans who rely on insurance for healthcare.
Long-term Implications for Vaccine Development
Beyond immediate policy concerns, experts have raised questions about the potential long-term effects on vaccine manufacturing and development. There are concerns that uncertainty in the U.S. regulatory environment could affect pharmaceutical companies’ willingness to invest in vaccine research and production for the American market. This restructuring may have implications beyond COVID-19 vaccines, potentially affecting policies for all vaccines including those for childhood illnesses and seasonal infections.
As the new committee takes shape, observers across the political spectrum are watching closely to see how vaccine recommendations might change and what this means for public health strategies moving forward. The reconstituted ACIP will face immediate challenges, including addressing pending recommendations for seasonal vaccines that millions of Americans rely on each year.
